Avandia :: American College of Cardiology, American Diabetes Association, American Heart Association on Avandia
The following is a Statement from the American College of Cardiology, American Diabetes Association and American Heart Association Related to NEJM article, ‘Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes’: